As of March 31, 2024, Medicamen Organics Ltd. has 11.70M shares outstanding.
| Shares Outstanding | 11.70M |
As of March 31, 2024, Medicamen Organics Ltd. maintains a current ratio of 1.26, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.26 |
| Quick Ratio | 0.03 |
| Debt / Equity | 82.94 |
As of the close on October 21, 2026, Medicamen Organics Ltd.'s stock has declined approximately 29.89% over the past 52 weeks. The 50-day moving average sits at 24.75, while the 200-day moving average is 24.96.
| 52-Week Price Change | -29.89% |
| 50-Day Moving Average | 24.75 |
| 200-Day Moving Average | 24.96 |
As of March 31, 2024, Medicamen Organics Ltd. holds 5.53M in cash and equivalents against 126.57M in total debt, resulting in a net debt position of 121.04M. Total book value stands at 152.59M, with working capital of 56.93M providing operational flexibility.
| Cash & Cash Equivalents | 5.53M |
| Total Debt | 126.57M |
| Net Debt | 121.04M |
| Equity (Book Value) | 152.59M |
| Book Value Per Share | 13.04 |
| Working Capital | 56.93M |
Already premium?